CLPT Cash Flow Breakdown | ClearPoint Neuro, Inc.

ClearPoint Neuro, Inc. Cash Flow Breakdown

Cash flow breakdown shows where ClearPoint Neuro, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

Fiscal year ended 2025-12-31: from running the business, $23.90M went out.
Fiscal year ended 2025-12-31: from investing, $615.00K came in.
Fiscal year ended 2025-12-31: from financing, $50.18M came in.
Fiscal year ended 2025-12-31: change in cash, $26.87M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year end	Running the business	From investing	Debt paid back	Staff share tax	New shares sold	Not split out	Change in cash
2025-12-31	-$23.90M	$615.00K		-$1.86M	$3.26M	$48.77M*	$26.87M
2024-12-31	-$8.95M	-$275.00K		-$424.00K	$16.15M	-$9.54M*	-$3.04M
2023-12-31	-$13.72M	$8.95M		-$210.00K*	$0.00		-$4.47M
2022-12-31	-$16.17M	-$10.74M		-$336.00K*	$0.00		-$26.49M
2021-12-31	-$12.70M	-$168.00K	$0.00	-$599.00K*	$46.78M		$34.01M
2020-12-31	-$7.81M	-$482.00K	-$2.84M	$0.00	$0.00	$25.53M*	$14.40M
2019-12-31	-$2.85M	-$160.00K	-$2.14M			$7.74M*	$2.60M
2018-12-31	-$4.63M	-$63.49K	-$2.00M			$505.38K*	-$6.19M
2017-12-31	-$5.99M	-$26.75K				$11.99M*	$5.97M
2016-12-31	-$5.82M	-$101.00K				$3.83M*	-$2.09M
2015-12-31	-$8.64M	-$76.88K				$4.88M*	-$3.84M
2014-12-31	-$7.25M	-$48.13K			$143.00K	$12.88M*	$5.73M
2013-12-31	-$7.78M	-$174.47K			$19.63K	$9.83M*	$1.90M
2012-12-31	-$7.43M	-$127.45K				$9.04M*	$1.47M
2011-12-31	-$6.24M	-$26.10K				$4.83M*	-$1.43M
2010-12-31	-$7.71M	-$61.70K				$6.78M*	-$991.82K

Each quarter (3 month)

Quarter end	Running the business	From investing	Debt paid back	Staff share tax	New shares sold	Not split out	Change in cash
2026-06-30	-$7.01M*	-$214.00K*		$0.00*	$455.00K*	$546.00K*
2026-03-31	-$7.97M	-$645.00K		-$1.99M	$148.00K		-$10.46M
2025-12-31	-$12.05M*	$1.09M*		-$195.00K*	$0.00*	$19.76M*
2025-09-30	-$3.12M*	-$199.00K*		$0.00*	$0.00*
2025-06-30	-$2.55M*	-$91.00K*		-$356.00K*	$3.26M*	$29.07M*
2025-03-31	-$6.17M	-$183.00K		-$1.30M	$0.00		-$7.72M
2024-12-31	-$1.24M*	-$263.00K*		-$84.00K*	-$34.00K*
2024-09-30	-$1.20M*	-$12.00K*		-$61.00K*	$0.00*	-$10.00M*
2024-06-30	-$2.67M*	$0.00*		-$128.00K*	$0.00*
2024-03-31	-$3.84M	$0.00		-$151.00K	$16.18M		$12.21M
2023-12-31	-$1.17M*	-$188.00K*		-$37.00K*	$0.00*
2023-09-30	-$1.80M*	-$235.00K*		-$91.00K*	$0.00*
2023-06-30	-$5.08M*	$9.51M*		-$77.00K*	$0.00*
2023-03-31	-$5.68M	-$138.00K		-$5.00K	$0.00		-$5.82M
2022-12-31	-$3.06M*	$11.75M*		$0.00*	$0.00*
2022-09-30	-$3.85M*	-$631.00K*		-$336.00K*	$0.00*
2022-06-30	-$4.98M*	-$21.67M*		$0.00*	$0.00*	$513.00K*
2022-03-31	-$4.27M	-$185.00K		$0.00	$0.00		-$4.45M
2021-12-31	-$3.55M*	-$38.00K*		-$57.00K*	$0.00*
2021-09-30	-$3.30M*	-$125.00K*			$0.00*
2021-06-30	-$3.72M*	$35.00K*			$0.00*
2021-03-31	-$2.13M	-$40.00K			$46.78M		$44.76M
2020-12-31	-$2.40M*	-$41.00K*	$0.00*			$7.88M*
2020-09-30	-$1.37M*	$0.00*	$0.00*
2020-06-30	-$1.71M*	$0.00*	$0.00*			$764.00K*
2020-03-31	-$2.33M	-$441.00K	-$2.84M			$16.89M*	$11.28M
2019-12-31	-$466.30K*	$190.00*	$344.00*				-$539.45K*
2019-09-30	-$964.13K*	-$10.19K*	-$162.34K*				-$1.23M*
2019-06-30	-$810.11K*						$4.97M*
2019-03-31	-$609.46K						-$609.46K
2018-12-31	-$582.38K*	-$839.00*	$0.00*				-$609.81K*
2018-09-30	-$975.27K*	-$11.15K*				-$2.00M*	-$2.99M*
2018-06-30	-$1.11M*	-$30.85K*					-$816.26K*
2018-03-31	-$1.96M	-$20.65K					-$1.78M
2017-12-31	-$1.75M*	-$2.24K*					-$1.74M*
2017-09-30	-$1.68M*	-$21.38K*					-$1.71M*
2017-06-30	-$1.22M*						$10.77M*
2017-03-31	-$1.35M						-$1.35M
2016-12-31	-$1.11M*	-$678.00*					-$1.12M*
2016-09-30	-$1.42M*	$0.00*					$2.42M*
2016-06-30	-$1.68M*	-$22.68K*					-$1.57M*
2016-03-31	-$1.61M	-$77.65K					-$1.83M
2015-12-31	-$1.32M*	-$4.86K*					$3.56M*
2015-09-30	-$1.60M*	-$64.64K*					-$1.67M*
2015-06-30	-$2.92M*	-$742.00*					-$2.92M*
2015-03-31	-$2.80M	-$6.63K					-$2.81M
2014-12-31	-$1.99M*	-$36.54K*			$0.00*	$9.38M*	$7.35M*
2014-09-30	-$2.18M*	-$6.21K*			$0.00*		-$2.18M*
2014-06-30	-$1.72M*	-$2.99K*			$0.00*		-$1.72M*
2014-03-31	-$1.36M	-$2.39K			$143.00K	$3.50M*	$2.28M
2013-12-31	-$1.51M*	-$824.00*			$0.00*		-$1.51M*
2013-09-30	-$1.84M*	-$117.80K*			$6.25K*		-$1.95M*
2013-06-30	-$2.19M*	-$47.86K*					-$2.22M*
2013-03-31	-$2.24M	-$7.99K				$9.83M*	$7.58M
2012-12-31	-$2.23M*	-$34.20K*					-$2.17M*
2012-09-30	-$1.95M*	-$8.39K*				$4.53M*	$2.56M*
2012-06-30	-$1.37M*	-$80.34K*				$989.52K*	-$458.93K*
2012-03-31	-$1.88M	-$4.52K				$3.42M*	$1.54M
2011-12-31	-$1.44M*	-$9.45K*				$1.52M*	$75.38K*
2011-09-30	-$1.32M*	-$14.92K*				$811.25K*	-$527.20K*
2011-06-30	-$1.91M*						$588.43K*
2011-03-31	-$1.57M						-$1.57M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Sight Sciences, Inc. (SGHT)	United States	$0.478B	-9.95
NeuroPace Inc (NPCE)	United States	$0.480B	-28.52
CARLSMED, INC. (CARL)	United States	$0.405B
Orthofix Medical Inc. (OFIX)		$0.373B
TACTILE SYSTEMS TECHNOLOGY INC (TCMD)	United States	$0.519B	27.16
CERUS CORP (CERS)	United States	$0.525B	-86.40
Orchestra BioMed Holdings, Inc. (OBIO)	United States	$0.356B	-4.39
SHOULDER INNOVATIONS, INC. (SI)	United States	$0.355B
DELCATH SYSTEMS, INC. (DCTH)	United States	$0.558B	820.33
Embecta Corp. (EMBC)	United States	$0.319B	2.10